Tech Company Financing Transactions
XDx Funding Round
XDx closed a $26.5 million financing round on 1/5/2006. Backers included DAG Ventures, Burrill & Company and Integral Capital Partners.
Transaction Overview
Company Name
Announced On
1/5/2006
Transaction Type
Venture Equity
Amount
$26,500,000
Round
Undisclosed
Investors
DAG Ventures (Lead Investor) (John Cadeddu)
Proceeds Purpose
The recent round of financing follows numerous significant company milestones for its first product to market, AlloMap" molecular expression testing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3260 Bayshore Blvd.
Brisbane, CA 94005
USA
Brisbane, CA 94005
USA
Phone
Website
Email Address
Overview
XDx is a molecular diagnostics company, XDx is one of the first companies to develop and commercialize practical applications built on insights from the Human Genome Project.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Maag
Chief Medical Officer
James Yee
Chief Scientific Officer
John Sninsky
VP - Bus. Development
Matthew Meyer
VP - R & D
Mitch Nelles
Browse more venture capital transactions:
Prev: 1/4/2006: Transcept Pharmaceuticals venture capital transaction
Next: 1/6/2006: Athenix venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs